Biotech IV Monitor

MRNA — Moderna Inc.

$69.6B market cap · 7 upcoming readouts tracked

Clinical trial readout dates for Moderna Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is January 2027.

Next readoutJanuary 2027in ~2 months
Upcoming readouts72 Phase 3
Market cap$69.6B
Cash & investments$7.98Bas of Sep 30, 2026
Recent 8-K filings2latest 2026-11-16

Recently completed

The registry reports these trials have finished collecting primary data. Results often follow within months, and the company may already have reported.

Phase 1/2 mRNA-1403
Norovirus Acute Gastroenteritis · NCT05992935
October 2026
Primary data collected
Phase 3 mRNA-1345
Respiratory Syncytial Virus · NCT06067230
July 2026
Primary data collected
Phase 2 mRNA-1345
Respiratory Syncytial Virus · NCT06143046
May 2026
Primary data collected

Upcoming readouts

Phase 3 mRNA-1018-H5
Influenza · NCT07496450
January 2027
Ongoing
Phase 3 mRNA-1403
Acute Gastroenteritis; Norovirus Acute Gastroenteritis · NCT06592794
February 2027
Ongoing
Phase 2 mRNA-1647
Cytomegalovirus Infection · NCT05683457
March 2027
Ongoing
Phase 1/2 mRNA-3927
Propionic Acidemia · NCT04159103
August 2027
Recruiting
Phase 2 mRNA-1982
Lyme Disease · NCT07561294
November 2028
Ongoing
Phase 2 mRNA-1195
Multiple Sclerosis · NCT06735248
January 2029
Recruiting
Phase 2 mRNA-1283
SARS-CoV-2 · NCT07808697
August 2029
Recruiting

Target dates already passed

These dates have elapsed; the company may have reported, or guidance may have shifted.

Phase 1/2 mRNA-3745
Glycogen Storage Disease · NCT05095727
November 2026
Ongoing

Cash position

Moderna Inc. reported $7.98B in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-06). It reported net income of $162M for that quarter.

Recent SEC filings

8-K Material Agreement — partnership or licensing deal2026-11-16
8-K Results of Operations — earnings, may carry pipeline updates2026-11-06

Companies working on similar indications

Discussion

No messages yet. If you follow MRNA, you can start the conversation.
Track MRNA in real time
See live implied volatility for MRNA and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on MRNA
Contact — questions or corrections about MRNA: dukeupt@gmail.com